PLUR

#4500
Pluri Inc. Common Stock
3.4600 USD
+1.76%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
3.4600
3.4600
년간 변동
3.0100
3.8220
일일 변동
+1.76%
월간 변동
+4.37%
6달 변화
-9.47%
년간 변동율
-9.47%
이전 종가
3.4000
Open
3.4600
Bid
Ask
Low
3.4600
High
3.4600
양
1
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 34.7756 M
  • Employee 142
  • Founded 2001
  • CEO Yaky Yanay
  • Website www.pluri-biotech.com
  • Headquarter Nevada, United States
  • FIGI BBG000DQX509
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.9
Price to sales ratio
16.22

Pluri Inc

Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.

뉴스